)

Mangoceuticals (MGRX) investor relations material
Mangoceuticals Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Revenue for Q2 2025 was $168,109, up slightly from $163,163 in Q2 2024, driven by increased customers for MangoRx and PeachesRx products.
Net loss for Q2 2025 widened to $5,415,820 from $2,391,319 in Q2 2024, mainly due to higher general and administrative expenses and increased stock-based compensation.
The company continued to invest in intellectual property, entering and later rescinding several master distribution and IP agreements, and expanded its product portfolio.
Significant equity and debt financing activities occurred, including private placements, warrant exercises, and convertible note conversions.
As of June 30, 2025, the company had $101,019 in cash and a working capital deficit of $1.48 million, raising substantial doubt about its ability to continue as a going concern without additional funding.
Financial highlights
Q2 2025 revenue: $168,109 (Q2 2024: $163,163); six-month revenue: $277,415 (2024: $377,258).
Q2 2025 net loss: $5,415,820 (Q2 2024: $2,391,319); six-month net loss: $10,255,309 (2024: $4,758,936).
Gross profit for Q2 2025: $89,948 (Q2 2024: $69,792); six-month gross profit: $152,012 (2024: $217,190).
Operating expenses for Q2 2025: $5,358,443 (Q2 2024: $2,238,433); six-month operating expenses: $10,273,696 (2024: $4,753,448).
Stock-based compensation for Q2 2025: $3,120,445 (Q2 2024: $859,380); six-month: $4,165,924 (2024: $1,313,845).
Outlook and guidance
Management anticipates the need for additional funding to continue operations and execute growth plans over the next 12 months.
The company plans to expand organically and through acquisitions, focusing on technology, health, and wellness sectors.
Strategic alternatives, including mergers, acquisitions, and divestitures, are being evaluated to maximize shareholder value.
Next Mangoceuticals earnings date

Next Mangoceuticals earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage